OptimizeRx (NASDAQ:OPRX – Get Free Report) and WNS (NYSE:WNS – Get Free Report) are both computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, earnings and risk.
Analyst Recommendations
This is a breakdown of recent recommendations and price targets for OptimizeRx and WNS, as provided by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
OptimizeRx | 0 | 1 | 6 | 0 | 2.86 |
WNS | 0 | 3 | 3 | 0 | 2.50 |
OptimizeRx presently has a consensus price target of $10.42, suggesting a potential upside of 99.17%. WNS has a consensus price target of $60.33, suggesting a potential upside of 26.09%. Given OptimizeRx’s stronger consensus rating and higher probable upside, equities analysts plainly believe OptimizeRx is more favorable than WNS.
Insider and Institutional Ownership
Profitability
This table compares OptimizeRx and WNS’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
OptimizeRx | -27.41% | -4.92% | -3.41% |
WNS | 9.39% | 22.76% | 11.93% |
Volatility and Risk
OptimizeRx has a beta of 1.34, suggesting that its stock price is 34% more volatile than the S&P 500. Comparatively, WNS has a beta of 1.14, suggesting that its stock price is 14% more volatile than the S&P 500.
Valuation and Earnings
This table compares OptimizeRx and WNS”s revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
OptimizeRx | $88.18 million | 1.09 | -$17.57 million | ($1.33) | -3.93 |
WNS | $1.31 billion | 1.75 | $140.15 million | $2.60 | 18.40 |
WNS has higher revenue and earnings than OptimizeRx. OptimizeRx is trading at a lower price-to-earnings ratio than WNS, indicating that it is currently the more affordable of the two stocks.
Summary
WNS beats OptimizeRx on 9 of the 14 factors compared between the two stocks.
About OptimizeRx
OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.
About WNS
WNS (Holdings) Limited, a business process management (BPM) company, provides data, voice, analytical, and business transformation services worldwide. The company operates through TSLU, MRHP, HCLS, and BFSI segments. It engages in diversified business, including manufacturing, retail, consumer packaged goods, media and entertainment, and telecommunication; travel and leisure, utilities, shipping, and logistics; healthcare and life sciences; banking, financial services, and insurance; and Hi-tech and professional services, as well as procurement. In addition, the company provides a range of services, such as finance and accounting, customer experience, research and analytics, technology, legal, and human resources outsourcing services. Further, it offers digital transformation and consulting services designed to allow its clients to enhance productivity, manage changes in the business environment, and leverage business knowledge to increase market competitiveness. Additionally, the company provides claims handling and repair management services for automobile repairs through a network of third-party repair centers, as well as accident management services. WNS (Holdings) Limited was founded in 1996 and is based in Mumbai, India.
Receive News & Ratings for OptimizeRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptimizeRx and related companies with MarketBeat.com's FREE daily email newsletter.